The inherent value of staging in the management of gynaecological cancers
| dc.contributor.author | Van Aardt, M.C. (Matthys Cornelis) | |
| dc.date.accessioned | 2013-06-26T06:24:21Z | |
| dc.date.available | 2013-06-26T06:24:21Z | |
| dc.date.issued | 2013-05 | |
| dc.description.abstract | Staging can be defined as assessing the anatomical extent of the tumour. Stages are an artificial subdivision of the ongoing disease process based on the applicable anatomical landmarks. The main goals in treating patients with cancer are to improve cure rates, increase survival time and enhance quality of life. The most crucial factor pertaining to cancer outcome is the disease extent at the time of presentation. The stage of the disease is used to indicate this extent. This is essential to optimally manage the cancer patient. | en_US |
| dc.description.librarian | am2013 | en_US |
| dc.description.uri | www.ogf.co.za | en_US |
| dc.identifier.citation | Van Aardt, MC 2013, 'The inherent value of staging in the management of gynaecological cancers', Obstetrics and Gynaecology Forum, vol. 23, no. 2, pp. 36-40. | en_US |
| dc.identifier.issn | 1029-1962 | |
| dc.identifier.uri | http://hdl.handle.net/2263/21715 | |
| dc.language.iso | en | en_US |
| dc.publisher | In House Publications | en_US |
| dc.rights | In House Publications | en_US |
| dc.subject | Gynaecological cancers | en_US |
| dc.title | The inherent value of staging in the management of gynaecological cancers | en_US |
| dc.type | Article | en_US |